C88.80
Other malignant immunoproliferative diseases not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Other malignant immunoproliferative diseases NOS
- Other malignant immunoproliferative diseases with failed remission
Medical Intelligence & Overview
ICD-10 code C88.80 refers to a category of blood cancers known as other malignant immunoproliferative diseases that have not responded to treatment or have not achieved remission. These are complex conditions where abnormal immune cells grow uncontrollably, leading to serious health issues. This guide aims to provide an understanding of this diagnosis in a clear and patient-friendly manner.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect immune cell regulation Prolonged exposure to certain chemicals or radiation Chronic infections that influence immune system behavior Underlying immune system disorders Chemotherapy or immunosuppressive treatments that alter immune cell function Unknown factors in many cases, as exact causes often remain unclear
Key Symptoms: Unexplained weight loss Persistent fever without an obvious cause Night sweats Swollen lymph nodes or enlarged organs such as the spleen or liver Fatigue and weakness Frequent infections due to immune system impairment Bone pain or tenderness Difficulty breathing or coughing if lymph nodes in the chest are enlarged
Diagnostic & Treatment
Diagnosis Path: Blood tests to examine the number and type of abnormal cells Bone marrow biopsy to assess marrow health and cell growth Imaging studies like CT scans or PET scans to identify affected lymph nodes and organs Immunophenotyping to determine the specific markers on abnormal cells Molecular tests to detect genetic mutations or specific abnormalities Comprehensive clinical evaluation to correlate symptoms and test results
Treatment Protocols: Chemotherapy to target and destroy cancerous cells Targeted therapy drugs that focus on specific molecular features of the disease Immunotherapy to enhance or restore immune function Stem cell or bone marrow transplantation in eligible cases Supportive care including medications to manage symptoms, infections, or blood cell counts Clinical trials exploring new treatment options for better outcomes
Clinical Advice & FAQs
Billing Guidance
Is C88.80 a billable ICD-10 code?
Yes, C88.80 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C88.80?
Clinical documentation must specify the nature of Other malignant immunoproliferative diseases not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference